Understanding Wegovy vs Mounjaro: Which Starter Dose?
Is Wegovy The Same As Mounjaro? Key Differences Explained
The fundamental difference between Wegovy and Mounjaro lies in their mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, helping reduce appetite and promote satiety after smaller meals. Mounjaro contains tirzepatide, which targets both GIP and GLP-1 receptors, offering a dual-action approach to weight management. Both are prescription-only medicines that must be used alongside a reduced-calorie diet and increased physical activity. The choice between them often depends on individual patient factors, medical history, and prescriber guidance.
When considering starter doses, Wegovy begins at 0.25mg for the first four weeks, allowing your body to gradually adjust to the medication. Mounjaro starts at 2.5mg weekly, representing a different dosing philosophy. Both medications require careful dose escalation under medical supervision, and you cannot skip doses safely. The starter phase is crucial for minimising side effects whilst establishing the foundation for long-term weight management success.
Wegovy vs Mounjaro Starter Pricing: Complete Cost Breakdown
Wegovy's starter dose costs £79.99 for the 0.25mg pen, covering your first four weeks of treatment. New customers can apply code FIRST40 at checkout to reach this price, whilst returning customers use code DOSE25. Our Intro Duo bundle (0.25mg and 0.5mg) costs £169.99, providing convenience for your first two months without multiple orders. This transparent pricing helps you plan your weight management investment from the very beginning.
For those wanting extended supply security, our Gentle Start Trio includes two 0.25mg pens plus one 0.5mg pen for £269.99, allowing you to extend the initial dose if needed based on your prescriber's guidance. This flexibility proves valuable for patients who may need slower titration. Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment and dosing approach aligns best with your medical profile and lifestyle preferences.
Clinical Evidence: Is Wegovy The Same As Mounjaro In Effectiveness?
Wegovy's clinical efficacy was demonstrated in the STEP trial programme, where patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 5 trial showed sustained weight loss of 15.2% at two years, indicating long-term effectiveness when treatment continues. These results established Wegovy's position as a significant advancement in prescription weight management options.
Mounjaro's clinical trials showed different outcomes due to varying study designs, populations, and endpoints, making direct comparison inappropriate. Both medications have demonstrated meaningful weight loss potential in their respective clinical programmes. The important consideration for patients isn't which performed better in trials, but which treatment suits their individual medical circumstances, tolerance profile, and treatment goals as determined through clinical assessment.
How Wegovy Works: Understanding The GLP-1 Mechanism
Wegovy functions as a GLP-1 receptor agonist, essentially mimicking the action of glucagon-like peptide-1, a hormone your intestines naturally produce after eating. This hormone signals your brain's appetite centres, promoting feelings of fullness and satisfaction after smaller portions. By activating these same receptors, Wegovy may help reduce overall food intake and decrease cravings for high-calorie foods. The medication works centrally in the brain's hypothalamus, the region responsible for hunger and satiety regulation. Additionally, Wegovy slows gastric emptying, meaning food stays in your stomach longer, contributing to prolonged feelings of fullness. This multi-faceted approach addresses both the psychological and physiological aspects of appetite control, supporting sustainable behaviour changes when combined with lifestyle modifications.
Starting Your Wegovy Journey: Simple Assessment Process
Beginning Wegovy through EverydayMeds requires just a 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our GPhC-registered prescribers (#9012878) review your assessment within three working days, or within 24 hours if you select express service. Once approved, your starter dose ships via next-day delivery using temperature-controlled cold-chain logistics to ensure medication integrity. The entire process from assessment to delivery typically takes 4-5 days, getting you started quickly whilst maintaining clinical safety standards. Our clinical team remains available throughout your treatment journey for guidance and support as you progress through the dose escalation schedule.
Storage and Practical Considerations: Wegovy vs Mounjaro Differences
Wegovy offers significant storage advantages, remaining stable at room temperature (below 30°C) for up to six weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This flexibility proves invaluable for travel, work schedules, or situations where refrigeration isn't consistently available. The FlexTouch pen design provides intuitive injection with clear dose confirmation and a pre-attached needle system. Before first use, store Wegovy in your refrigerator at 2-8°C, and never freeze or expose to direct heat or sunlight. Each pen delivers exactly four doses, perfectly matching the weekly injection schedule, and the dose counter clearly shows remaining medication. This user-friendly design supports treatment adherence during those crucial starter weeks when establishing your routine.
Starter Dose Success: Is Wegovy The Same As Mounjaro For Beginners?
For first-time patients, the starter dose experience differs significantly between treatments. Wegovy's 0.25mg beginning allows very gradual introduction, typically resulting in mild appetite changes and manageable side effects like occasional nausea. Most patients tolerate this initial dose well, with appetite reduction becoming noticeable within the first week or two. The four-week duration at this dose provides ample time for your body to adjust before progressing to 0.5mg.
Mounjaro's starter approach begins at 2.5mg, representing a higher initial exposure that may suit some patients better than others. The key consideration isn't which starter dose is superior, but which approach aligns with your tolerance profile and medical history. Our clinical assessment helps identify patients who may benefit from Wegovy's gentler introduction versus those who might prefer Mounjaro's different profile, ensuring the most appropriate choice for your individual circumstances.
Begin Your Weight Management Journey Today
Ready to discover whether Wegovy suits your weight management goals? Complete our clinical assessment to determine if this prescription-only medicine is appropriate for your circumstances. New customers use code FIRST40 at checkout, whilst returning customers apply code DOSE25 for our transparent pricing. Your journey begins with the 0.25mg starter dose at £79.99, delivered next-day once approved by our prescribers. Visit https://everydaymeds.co.uk/products/wegovy-0-25mg to start your assessment today. Remember, both Wegovy and Mounjaro are available from EverydayMeds, and our clinical team will help you choose the most suitable option. Weight management is a long-term commitment, and we're here to support you every step of the way through our GPhC-registered pharmacy services.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
